CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,298 | $549.06 | $713K | 18,996 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $550.48 | $66K | 18,876 |
| 2026-06-04 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 30,000 | ||
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $539.51 | $65K | 49,893 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −473 | $541.08 | $256K | 49,420 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −112 | $542.50 | $61K | 49,308 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −396 | $543.11 | $215K | 48,912 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,470 | $544.24 | $800K | 47,442 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,186 | $545.18 | $647K | 46,256 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,202 | $546.14 | $656K | 45,054 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,525 | $547.53 | $835K | 43,529 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,676 | $548.26 | $919K | 41,853 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −780 | $549.24 | $428K | 41,073 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −560 | $550.46 | $308K | 40,513 |
| 2026-06-04 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 97,910 | ||
| 2026-06-04 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
| 2026-06-04 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $539.76 | $108K | 53,272 |
| 2026-06-04 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −840 | $543.89 | $457K | 52,432 |
| 2026-06-04 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −374 | $545.27 | $204K | 52,058 |
Page 89 of 120 · 2,391 trades